ALK-Abello A/S operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Christian Hansen Holding with three other
pharmaceutical manufacturers in Europe:
Bavarian Nordic AS
sales of 500.62 million Danish Kroner [US$74.10 million]
of which 100%
(26.74 million Euro [US$29.58 million]
of which 95%
was Product Sales), and
Horizon Discovery Group PLC
based in the United Kingdom
(£58.73 million [US$77.18 million]
of which 79%
Christian Hansen Holding reported sales of 2.92 billion Danish Kroner (US$431.48 million)
December of 2018.
a very small
increase of 0.2%
versus 2017, when the company's sales were 2.91 billion Danish Kroner.
Despite this increase, sales are still
below the level achieved in 2016, when Christian Hansen Holding
reported sales of 3.01 billion Danish Kroner.
Sales of Slit - Tablets saw an increase
that was more than double the company's growth rate: sales were up
27.1% in 2018, from
528.00 million Danish Kroner to 671.00 million Danish Kroner.
Christian Hansen Holding also saw significant increases in sales in
Other Products and Services (up 0.4% to 467.00 million Danish Kroner)
Not all segments of Christian Hansen Holding experienced an increase in sales in 2018:
sales of Scit/slit Drops fell 7.3% to 1.78 billion Danish Kroner.